Tweet
I am doing RNA-Seq, of mRNA by polyA bead selection. In the protocol I am using, it says to heat treat the mRNA for fragmentation. It does heat treatments at 94C at varying time lengths for varying size fragments. It then says to transfer the heated samples to a magnet so that the hot beads bind to the magnet. I wasn't watching the temperature drop back down on my thermocycler and by the time I did, the thermocycler was at 42C. I quickly transferred my samples to the magnet. But since the temperature dropped from 94C to 42C, will I lose yield of my mRNA? Or what kinds of problems will I run into? Is anyone familiar with different mRNA fragmentation treatments? Is 94C necessary?
-
-
The beads need to be magnetized while still hot so that the mRNA fragments containing poly(A) tails or internal poly(A) stretches will not have a chance to re-hybridize to the oligo d(T) beads. So in the situation you described, I think the biggest problem will be lower representation of these fragments in your final library. Re-heating the beads to 80 degrees and then placing them immediately on the magnet should allow recovery of these fragments without further fragmentation of the rest of the material.
I believe the temperature used for fragmentation depends on the divalent cation used in the fragmentation buffer- most library prep kits use magnesium (which is conveniently already present in RT buffer) so 94 degrees is the recommended temperature, whereas zinc-based fragmentation, such as that sold by Ambion, is performed at 70 degrees.
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment